Regeneron will provide 300,000 doses of Covid treatment for U.S. by early January, CEO Schleifer says

Regeneron will provide the U.S. with 300,000 doses of its newly authorized Covid-19 antibody treatment by early January, CEO Dr. Leonard Schleifer said.

from Health and Science https://ift.tt/3kWnkw0
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH